Nonmember individuals interested in joining the AACR and sponsoring an abstract for AACR Annual Meeting 2024 must submit an application for membership no later than November 10, 2023. Individuals interested in joining the AACR and sponsoring a clinical trial or late-breaking abstract must submit an a...
Nonmember individuals interested in joining the AACR and sponsoring an abstract for AACR Annual Meeting 2024 must submit an application for membership no later than November 10, 2023. Individuals interested in joining the AACR and sponsoring a clinical trial or late-breaking abstract must submit an a...
ICERI 2024 - The 17th Annual International Conference of Education, Research and Innovation AI World Congress 2024 International Conference on Trends and Innovations in Management, Engineering, Sciences and Humanities (ICTIMESH 2024) 35th Annual Art and Science of Health Promotion Conference ...
April 12th 2024 Experts from across the oncology field highlight their biggest takeaways and the hottest topics from the 2024 AACR Annual Meeting. Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma By Ryan Scott April 11th 2024 Nivolumab plus talazoparib did not pr...
3. Piperno-Neumann S, et al. Abstract CT002. Presented at: American Association for Cancer Research Annual Meeting (virtual meeting); April 10-15, 2021. 4. Damato BE, Dukes J, Goodall H, Carvajal RD. Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma. Cancers...
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, will present at the American Association of Cancer Research (AACR) Virtual Annual Meeting II, occurring June...
today announced that data highlighting the development of BND-22, a first-in-class anti-Ig-like transcript 2 (ILT2) antibody, and CD28 shedding as a novel cancer immunotherapy target, were presented at the 2020 American Association of Cancer Research (AACR) Virtual Annual Me...
(Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it will present an abstract in a poster session at the 2020 American Association for Cancer Research (AACR) Virtual...
Data on multiple oncology therapeutic programs are being unveiled ahead of the start of the annual American Association for Cancer Research meeting, which will be held virtually this year due to the ongoing COVID-19 pandemic.
auto-immune diseases as well as inflammatory disorders, today announced that two posters highlighting preclinical data of the company's lead drug candidates, KPG-121 and KPG-818, will be presented at the 2020 American Association for Cancer Research (...